Skip to content
Open access · CC-BY via OpenAlex

DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma

Katharina Johanna Weber, Mareike Dettki, Marco Münzberg, Pia Susann Zeiner, Marie-Thérèse Forster, Eike Steidl, Iris Divé, Patrick N. Harter, Michael Scherer

Acta Neuropathologica · 2025

Abstract

IDH-mutant gliomas represent a subtype of diffuse gliomas that primarily affect patients in early to mid-adolescence. These tumors are classified into three distinct CNS WHO grades of malignancy. Accurate grading is essential for selecting an appropriate treatment maximizing anti-tumor efficacy while minimizing adverse effects. However, grading of oligodendrogliomas with 1p/19q codeletion currently relies on qualitative tumor characteristics that may be influenced by observer subjectivity, sampling bias, and tumor heterogeneity. This study aimed to explore DNA methylation-based tumor deconvolution into latent methylation components (LMCs) to evaluate their potential as objective grading tools in a cohort of 137 IDH-mutant gliomas. LMCs were analyzed in relation to malignancy markers, cellular composition, and underlying methylation signatures of the chromatin landscape. Glioma subtypes were associated with distinct LMCs. Two LMCs correlated with higher cellular density and advanced epigenetic age as well as with microvascular proliferation, necrosis, and epigenetically defined high-grade astrocytoma. The epigenetic patterns defining high-grade astrocytoma or oligodendroglioma, respectively, were similar. Higher-grade oligodendrogliomas, identified by LMC-based grading, were associated with more copy number alterations. Among patients of an external cohort who died during the assessment period, higher LMC1 proportions were associated with poorer overall survival. Therefore, LMCs hold the potential to support IDH-mutant glioma grading by incorporating objective epigenetic markers.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1007/s00401-025-02926-y
Canonical
link ↗
Fetched
2026-10-04 MST

Cite this

APA
Weber, K.J., Dettki, M., Münzberg, M., Zeiner, P.S., Forster, M., Steidl, E., Divé, I., Harter, P.N., &amp; Scherer, M. (2025). DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma. <em>Acta Neuropathologica</em>. https://doi.org/10.1007/s00401-025-02926-y
Vancouver
Weber KJ, Dettki M, Münzberg M, Zeiner PS, Forster M, Steidl E, et al. DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma. Acta Neuropathologica. 2025. doi:10.1007/s00401-025-02926-y.
BibTeX
@article{katharina2025DNAmet, title = {DNA methylation analysis reveals an epigenetic signature distinctive of high-grade oligodendroglioma}, author = {Katharina Johanna Weber and Mareike Dettki and Marco Münzberg and Pia Susann Zeiner and Marie-Thérèse Forster and Eike Steidl and Iris Divé and Patrick N. Harter and Michael Scherer}, journal = {Acta Neuropathologica}, year = {2025}, doi = {10.1007/s00401-025-02926-y}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings